Arvin Yang
2020
In 2020, Arvin Yang earned a total compensation of $4.5M as Chief Medical Officer at Mersana Therapeutics.
Compensation breakdown
| Option Awards | $3,523,840 |
|---|---|
| Salary | $44,462 |
| Stock Awards | $942,760 |
| Total | $4,511,062 |
Yang received $3.5M in option awards, accounting for 78% of the total pay in 2020.
Yang also received $44.5K in salary and $942.8K in stock awards.
Rankings
In 2020, Arvin Yang's compensation ranked 2,500th out of 13,090 executives tracked by ExecPay. In other words, Yang earned more than 80.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,500 out of 13,090 | 81st |
Division Manufacturing | 955 out of 5,618 | 83rd |
Major group Chemicals And Allied Products | 344 out of 2,251 | 85th |
Industry group Drugs | 295 out of 1,951 | 85th |
Industry Pharmaceutical Preparations | 213 out of 1,456 | 85th |
Source: SEC filing on April 27, 2021.
Yang's colleagues
We found four more compensation records of executives who worked with Arvin Yang at Mersana Therapeutics in 2020.
2020
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
2020
Timothy Lowinger
Mersana Therapeutics
Chief Science and Technology Officer
2020
Michael Kaufman
Mersana Therapeutics
Chief Manufacturing Officer
2020
Brian DeSchuytner
Mersana Therapeutics
Senior Vice President, Finance & Product Strategy
News
Mersana Therapeutics CEO Anna Protopapas' 2023 pay jumps 56% to $4.5M
April 26, 2024
Mersana Therapeutics CEO Anna Protopapas' 2022 pay falls 66% to $2.8M
April 28, 2023
Mersana Therapeutics CEO Anna Protopapas' 2021 pay jumps 226% to $8.3M
April 29, 2022
Mersana Therapeutics Chief Medical Officer Arvin Yang receives $4.5M in 2020
April 27, 2021